dsm-firmenich completes the divestiture of its Jiangshan vitamin C plant in China

Published: 8-Mar-2024
Finance

Financial details of the transaction were not disclosed

dsm-firmenich has announced the successful sale and transfer of its 100% equity interest in DSM Jiangshan Pharmaceutical Co., Ltd to Jingjiang Cosfocus Health Technology Co., Ltd.

dsm-firmenich announced on 28 June 2023 it was exploring a range of options for the Jiangshan vitamin C plant in Jinjiang, China.
 

  • Companies:
  • dsm-firmenich
See more

You may also like

Finance

KD Pharma Group completes acquisition of dsm-firmenich's Marine Lipids business

Read more
The transaction positions KD Pharma Group as the largest omega-3 manufacturer in the world

Trending Articles

  1. ARTAH Nutrition bags £2.85m investment to grow its dietary supplement business The company will use the investment to expand the reach of its metabolic health-boosting supplements across Europe
  2. Arla Foods Ingredients one step closer to getting the Volac acquisition go-ahead This follows the UK Competition and Market Authority's approval of Arla's acquisition of Volac's whey nutrition business
  3. Miura Partners becomes the majority shareholder of HealthTech BioActives The nutraceutical specialist will now be able to grow its functional health, taste modulation and animal nutrition divisions
  4. OmniActive acquires functional ingredients specialist, ENovate Biolife The purchase will bolster OmniActive's range of botanical nutraceuticals for active nutrition, joint health, heart health and men's wellness
  5. Green Bioactives receives £224,000 to develop its plant metabolite biomanufacturing platform The funding from Innovate UK will allow the company to accelerate the development of its botanical metabolite biomanufacturing platform

Upcoming event

Fi Europe 2024

19-21 November 2024 | Exhibition | Frankfurt, Germany See all

You may also like

Finance

KD Pharma Group completes acquisition of dsm-firmenich's Marine Lipids business

The transaction positions KD Pharma Group as the largest omega-3 manufacturer in the world
Finance

KD Pharma secures dsm-firmenich's MEG-3 fish oil business in strategic acquisition

KD Pharma will gain all of the MEG-3's assets, including two production facilities and around 200 employees
Finance

dsm-firmenich announces sale of yeast extract business to Lesaffre

dsm-firmenich, innovators in nutrition, health and beauty, has announced an agreement to sell its yeast extract business (Yeast Extracts) to Lesaffre, a key global player in fermentation and micro-organisms
Finance

dsm-firmenich completes on-market repurchase of 500,000 shares to cover share plans

The company has repurchased 500,000 shares for a total consideration of €51.6m
Ingredients

dsm-firmenich announces repurchase of 1.5m shares to cover share plans

The repurchasing of shares equates to around €156m
Finance

dsm-firmenich to separate out Animal Nutrition & Health business from the Group

The company will be placing a full focus on nutrition, health and beauty
Finance

dsm-firmenich completes voluntary cash offer for DSM shares

4,163,287 shares, representing approximately 2.4% of the company’s share availability, have been tendered to the company under the voluntary tender offer
Subscribe now